首页 › 基金 › MPM BioImpact LLC › VIR
MPM BioImpact LLC 对 VIR 的持仓历史
VIR BIOTECHNOLOGY INC · 医疗保健
MPM BioImpact LLC 在 Q3 2026 的 13F 申报中披露持有 VIR(VIR BIOTECHNOLOGY INC)2,809,711 股,市值约 US$31.4M,约占其申报组合的 2.42%,在其申报持仓中市值排名第 17 位。 MPM BioImpact LLC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
MPM BioImpact LLC 对 VIR 的持仓演变
MPM BioImpact LLC 于 Q3 2026 首次披露 VIR 持仓:2,809,711 股(约 US$31.4M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 2.81M | $31.41M | 新进 |
关于 VIR 与 13F 数据
VIR(VIR BIOTECHNOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 38 只申报持有 VIR,申报仓位最大的包括:ARCH Venture Management, LLC (US$141.9M), SB INVESTMENT ADVISERS (UK) LTD (US$111.6M), GSK plc (US$95.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 VIR 的基金
- ARCH Venture Management, LLC 12.69M 股 · $141.92M · Q3 2026
- SB INVESTMENT ADVISERS (UK) LTD 10.95M 股 · $111.56M · Q2 2026
- GSK plc 8.55M 股 · $95.60M · Q3 2026
- ADAR1 Capital Management, LLC 2.16M 股 · $24.14M · Q3 2026
- Saturn V Capital Management LP 2.04M 股 · $22.81M · Q3 2026
- Sio Capital Management, LLC 873.38K 股 · $9.76M · Q3 2026
- GordonMD Global Investments LP 803.55K 股 · $8.98M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 578.70K 股 · $6.47M · Q3 2026
更多关于 MPM BioImpact LLC
常见问题
How long has MPM BioImpact LLC held VIR?
MPM BioImpact LLC has disclosed VIR holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is MPM BioImpact LLC's current position in VIR?
As of Q3 2026, MPM BioImpact LLC holds 2.81M shares of VIR (VIR BIOTECHNOLOGY INC), valued at $31.41M, representing 2.42% of its reported portfolio and ranking #17.
Has MPM BioImpact LLC been buying or selling VIR?
In the latest 13F filing (Q3 2026), MPM BioImpact LLC newly opened its position in VIR.
Which other funds hold VIR?
Other major institutional holders of VIR include ARCH Venture Management, LLC, SB INVESTMENT ADVISERS (UK) LTD, GSK plc, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.